TIMOPTOL Ophthalmic Solution 0.5% is an original Japanese prescription eye medication containing Timolol Maleate, a non-selective beta-adrenergic blocker used to reduce elevated intraocular pressure in patients with glaucoma and ocular hypertension.
Manufactured by Santen Pharmaceutical, TIMOPTOL has been widely used in ophthalmology for many years due to its proven efficacy, consistent pressure-lowering effect, and excellent quality.
TIMOPTOL 0.5% is indicated for the treatment of:
Timolol reduces aqueous humor production within the eye, lowering intraocular pressure without significantly affecting pupil size or accommodation.
Lowering eye pressure helps protect the optic nerve and reduce the risk of progressive vision loss.
TIMOPTOL should be used only as prescribed by an ophthalmologist.
The dosage schedule depends on the patient's diagnosis and treatment plan. Regular monitoring of intraocular pressure is recommended during therapy.
Common adverse reactions may include:
Systemic beta-blocker effects may rarely occur, including:
Seek medical advice if serious symptoms develop.
Do not use in patients with:
Store according to the manufacturer's instructions, protected from excessive heat and direct sunlight. Follow the official recommendations after opening the bottle.
TIMOPTOL is a timolol-containing ophthalmic solution used to lower intraocular pressure in glaucoma and ocular hypertension.
It is commonly prescribed for glaucoma and elevated intraocular pressure.
Pressure reduction typically begins within 20–30 minutes after administration.
Yes. Many patients use TIMOPTOL for long-term glaucoma management under medical supervision.
Yes. Combination therapy is common and should be determined by an eye specialist.
Contact lenses should generally be removed before instillation and reinserted according to the product instructions or your ophthalmologist's advice.
Ask a question or inquire about delivery to your country

